Omitting FSH-stimulated cycles brings baby faster and cheaper

Article

Skipping the FSH-stimulated cycle usually results in a shorter time to pregnancy.

Skipping over the gonadotropin-stimulated artificial insemination cycles that usually precede in vitro fertilization (IVF) attempts results in a shorter time to pregnancy and less expense, as well as a lower risk for multiple births, according to the results of a recent randomized clinical trial.

The FASTT (the Fast Track and Standard Treatment Trial) included just over 500 couples with unexplained infertility. Approximately one half of the couples were treated conventionally with three cycles of clomiphene citrate (CC)/IUI, three cycles of gonadotropin/intrauterine stimulation (FSH/IUI), and up to six cycles of IVF, while the other half followed an accelerated protocol that omitted the three cycles of FSH/IUI.

Pregnancy was achieved about 25% faster in the accelerated group. Those couples became pregnant in an average of 8 months, compared with 11 months for the couples in the conventional arm of the study. And, on average, couples in the accelerated arm accumulated almost $10,000 less in total pregnancy and delivery charges than those in the conventional arm, partly because of the direct savings associated with foregoing the FSH/IUI, but also by greatly reducing the increased charges associated with multiple pregnancies and births.

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
© 2025 MJH Life Sciences

All rights reserved.